Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (321-330 of 365) with videos related to

Pageof 37
Sort By:
Plos One|March 2, 2013
SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructoseTaku Fukuzawa, Masanori Fukazawa, Otoya Ueda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 3, 2022
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinomaMasaaki Ito, Takaki Hiwasa, Satoshi Yajima, et al.
Cancer Science|March 26, 2011
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesotheliomaAtsushi Kitamura, Kazuyuki Matsushita, Yuichi Takiguchi, et al.
Proteome Science|June 24, 2011
Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinomaAkiko Kagaya, Hideaki Shimada, Tooru Shiratori, et al.
Journal of Gastroenterology|August 17, 2024
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 casesSho Sato, Takashi Suzuki, Takashi Chinen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 6, 2022
Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal SocietyTakashi Suzuki, Satoshi Yajima, Akihiko Okamura, et al.
Surgery|February 26, 2021
Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a multicenter retrospective studyKotaro Sugawara, Hiroharu Yamashita, Satoshi Yajima, et al.
Oncotarget|May 3, 2018
Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage librarySohei Kobayashi, Takaki Hiwasa, Takahiro Arasawa, et al.
International Journal of Clinical Oncology|April 28, 2024
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort studySho Sato, Takashi Ssuzuki, Takashi Chinen, et al.
Surgery Today|August 16, 2020
What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysisShohei Fujita, Yoko Oshima, Satoshi Yajima, et al.
Pageof 37

Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
Plos One|March 2, 2013
SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructoseTaku Fukuzawa, Masanori Fukazawa, Otoya Ueda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 3, 2022
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinomaMasaaki Ito, Takaki Hiwasa, Satoshi Yajima, et al.
Cancer Science|March 26, 2011
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesotheliomaAtsushi Kitamura, Kazuyuki Matsushita, Yuichi Takiguchi, et al.
Proteome Science|June 24, 2011
Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinomaAkiko Kagaya, Hideaki Shimada, Tooru Shiratori, et al.
Journal of Gastroenterology|August 17, 2024
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 casesSho Sato, Takashi Suzuki, Takashi Chinen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 6, 2022
Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal SocietyTakashi Suzuki, Satoshi Yajima, Akihiko Okamura, et al.
Surgery|February 26, 2021
Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a multicenter retrospective studyKotaro Sugawara, Hiroharu Yamashita, Satoshi Yajima, et al.
Oncotarget|May 3, 2018
Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage librarySohei Kobayashi, Takaki Hiwasa, Takahiro Arasawa, et al.
International Journal of Clinical Oncology|April 28, 2024
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort studySho Sato, Takashi Ssuzuki, Takashi Chinen, et al.
Surgery Today|August 16, 2020
What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysisShohei Fujita, Yoko Oshima, Satoshi Yajima, et al.
Pageof 37